RiverVest Venture Partners
St. Louis, Missouririvervest.com
Overview
RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value . With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit . RiverVest focuses exclusively on innovations in life sciences, a field in which their team has significant research, clinical, operational, and investment expertise .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sparrow Pharmaceuticals | Sep 2025 | Series B | Co-investor |
| Wugen | Aug 2025 | Early Funding | Co-investor |
| Allotera Therapeutics | Aug 2025 | Series C | Co-investor |
| Avalyn Pharma | Jul 2025 | Series D | Co-investor |
| Biolinq | Apr 2025 | Series C | Co-investor |
Key People
Jay Schmelter
Co-Founder And Managing Director
Nafise Masoumi
Principal
Marilyn Slavich
Consultant For Rivervest Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
